PATENT CLAIM ANALYSIS

Application Number: 16179672
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "210210"]

Abstract:
The present invention relates to new pyrrolopyridine compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibition of JAK1 and JAK3 kinase activity in a human or animal subject are also provided for the treatment diseases such as pruritus, alopecia, androgenetic alopecia, alopecia areata, vitiligo and psoriasis.

Claim (Index 10):
The compound of  claim 8 , wherein the compound is selected from the group consisting of:

Metadata:
- Claim Count in Document: 43.0
- Percentile: 98.0
- Lexical Diversity: 1.34091
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15672627', '15320120', '15377214', '14924427', '15585626']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7968642249776664
- 35 USC 102 Novelty (BERT): 0.5136766491450507
- Combined Prediction Score: 0.7685454673944049
- Mean Citation Score: 229.845596
- Max Citation Score: 234.2343
- Similarity Product: 131.7607448409855

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test